eye drops grade
Runxin Biotech
| Quantity: | |
|---|---|
High-Purity Ophthalmic-Grade Hyaluronic Acid for Lubricating Drops and Surgical Viscoelastic Applications
Sodium hyaluronate has become one of the most widely used biomaterials in ophthalmology. Its exceptional water-binding ability, biocompatibility, and viscoelastic properties make it ideal for both lubricating eye drops and surgical ophthalmic formulations. When supplied as a high-purity powder, sodium hyaluronate offers additional flexibility for formulation, sterilization, and storage.
In ophthalmic manufacturing, powder form allows producers to prepare solutions with precise viscosity and concentration according to the requirements of different clinical applications. From artificial tears designed to relieve dry eye symptoms to surgical viscoelastic solutions used during delicate procedures, sodium hyaluronate plays a critical role in maintaining tissue hydration and protecting sensitive ocular structures.
At Runxin Biotech, ophthalmic-grade sodium hyaluronate powder is produced through controlled fermentation and advanced purification processes. The result is a highly pure, stable material with low endotoxin levels and consistent molecular weight distribution. These characteristics ensure reliable performance during formulation and help meet strict regulatory requirements for ophthalmic products.
For companies developing eye drop formulations or surgical ophthalmic solutions, sodium hyaluronate powder offers a versatile starting point. It enables precise control over viscosity, solution clarity, and lubricating performance while maintaining excellent safety and compatibility with ocular tissues.
Sodium hyaluronate used for ophthalmic applications must meet higher purity and safety standards than cosmetic or topical grades. Several characteristics define its suitability for eye drops and surgical use.
Ophthalmic formulations require materials with extremely low impurity levels. High-grade sodium hyaluronate is purified to remove proteins, nucleic acids, and endotoxins that could cause irritation or inflammation.
Molecular weight directly affects viscosity, hydration capacity, and ocular retention time. Different ophthalmic formulations may require specific ranges to achieve the desired lubricating or viscoelastic effect.
Sodium hyaluronate can bind large amounts of water relative to its mass. This property allows eye drops to maintain moisture on the ocular surface and helps surgical formulations protect delicate tissues.
When properly dissolved, sodium hyaluronate forms a transparent, uniform solution that does not interfere with vision or surgical visualization.
Dry powder provides long shelf life and convenient transport while allowing manufacturers to prepare solutions at precise concentrations.
The eye is one of the most sensitive tissues in the human body. Materials used in ophthalmic formulations must combine biocompatibility with precise physical behavior.
Sodium hyaluronate meets these requirements through several mechanisms.
Hyaluronic acid naturally exists in the vitreous body and other connective tissues. Its presence in ophthalmic formulations supports compatibility and reduces the risk of adverse reactions.
In surgical procedures, sodium hyaluronate solutions provide cushioning and maintain space within the eye. This viscoelastic property protects delicate structures such as the corneal endothelium.
For dry eye treatment, sodium hyaluronate forms a hydrating film over the ocular surface. This film reduces friction between the eyelid and cornea and prolongs moisture retention.
Research suggests hyaluronic acid may contribute to epithelial repair and tissue regeneration, making it valuable in post-surgical recovery formulations.
Artificial tear products rely on sodium hyaluronate to mimic the natural lubrication of the tear film. The polymer’s ability to retain moisture and maintain viscosity makes it highly effective in dry eye treatments.
Many patients experience dry eye syndrome due to environmental conditions, prolonged screen exposure, aging, or medical conditions. Sodium hyaluronate eye drops help restore moisture and comfort.
A hydrated polymer layer protects epithelial cells and reduces irritation caused by blinking or environmental factors.
Compared with simple saline solutions, hyaluronic acid remains longer on the ocular surface, increasing therapeutic effectiveness.
Sodium hyaluronate can be combined with electrolytes, preservatives, or other ophthalmic ingredients depending on the product design.
Manufacturers often select specific molecular weights to optimize viscosity while ensuring comfortable application.
Sodium hyaluronate is also widely used in ophthalmic surgery as part of viscoelastic formulations.
During cataract procedures, viscoelastic solutions maintain space in the anterior chamber and protect corneal tissues.
The viscoelastic properties assist surgeons in manipulating tissues while reducing trauma.
Hyaluronic acid solutions can provide temporary support for delicate retinal structures.
Viscoelastic formulations help maintain stability during lens insertion.
These applications require extremely pure material with precise rheological properties.
Molecular weight strongly influences the performance of sodium hyaluronate solutions.
| Molecular Weight Range | Typical Function | Application Example |
|---|---|---|
| Low MW (0.3–0.8 MDa) | Lower viscosity | Light eye lubrication |
| Medium MW (0.8–1.5 MDa) | Balanced lubrication | Artificial tears |
| High MW (1.5–3.0 MDa) | Strong viscoelasticity | Surgical viscoelastic solutions |
Selecting the appropriate molecular weight allows formulators to tailor viscosity, lubrication, and retention time.
Many ophthalmic manufacturers prefer sodium hyaluronate in powder form rather than ready-made solutions.
| Feature | HA Powder | Pre-Made Solution |
|---|---|---|
| Shelf Life | Longer | Shorter |
| Transport Cost | Lower | Higher |
| Concentration Control | Flexible | Fixed |
| Storage Stability | Excellent | Limited |
Powder provides flexibility during formulation and simplifies logistics.
High-quality sodium hyaluronate begins with controlled microbial fermentation.
Modern fermentation technology produces hyaluronic acid with high purity and consistent molecular weight while avoiding animal-derived materials.
After fermentation, the material undergoes multiple purification steps to remove proteins, nucleic acids, and endotoxins.
Gentle drying processes preserve polymer structure while producing a stable powder suitable for long-term storage.
Manufacturing quality directly influences the safety and performance of ophthalmic products.
Ophthalmic sodium hyaluronate powder undergoes strict quality testing before release.
Typical parameters include:
| Parameter | Specification |
|---|---|
| Appearance | White or off-white powder |
| Molecular Weight | Customizable |
| Endotoxin | Very low |
| Protein Content | Minimal |
| Loss on Drying | Controlled |
| Solution Clarity | Clear |
These controls ensure consistent material performance in ophthalmic formulations.
Preparing sodium hyaluronate solutions from powder requires careful hydration.
General preparation steps include:
Add purified water or buffer solution to a sterile mixing vessel.
Slowly disperse sodium hyaluronate powder while stirring gently.
Allow sufficient hydration time to avoid clumping.
Adjust concentration according to formulation requirements.
Proper mixing conditions ensure uniform viscosity and clarity.
Packaging plays an important role in maintaining product quality.
Sodium hyaluronate powder is typically stored in moisture-proof containers with protective inner liners. Recommended storage conditions include:
Cool, dry environment
Protection from light
Controlled humidity
Under proper conditions, powder maintains stability for extended periods.
Different ophthalmic products require specific molecular weights and viscosities. Manufacturers often request customized material characteristics.
Runxin Biotech provides:
Multiple molecular weight options
Custom viscosity ranges
Technical documentation support
Sample supply for formulation testing
This flexibility allows manufacturers to develop both eye drop products and surgical viscoelastic solutions efficiently.
When developing ophthalmic formulations, consistency and purity are essential. Runxin Biotech focuses on controlled fermentation, advanced purification, and strict quality monitoring to ensure reliable sodium hyaluronate powder.
Key strengths include:
Long-term experience in hyaluronic acid production
Stable molecular weight control
Low endotoxin purification process
GMP-aligned manufacturing environment
Technical support for formulation development
These capabilities help pharmaceutical and medical device manufacturers create safe, high-performance ophthalmic products.
Medium molecular weight sodium hyaluronate is commonly used because it balances lubrication and comfort. However, the optimal range depends on the specific formulation.
Yes. Solutions prepared from sodium hyaluronate powder can be sterilized through appropriate filtration or terminal sterilization methods depending on formulation requirements.
When stored properly in sealed containers under dry conditions, the powder typically maintains stability for several years.
High-purity sodium hyaluronate produced through controlled fermentation is widely used in ophthalmic formulations and has a strong safety profile.
Sodium hyaluronate powder plays an essential role in both ophthalmic lubricating products and surgical viscoelastic formulations. Its ability to retain water, protect tissues, and provide controlled viscosity makes it a valuable ingredient for modern eye care solutions.
By selecting high-purity sodium hyaluronate produced through advanced fermentation and purification processes, manufacturers can develop eye drops and surgical formulations that meet strict safety and performance standards.
Runxin Biotech supplies pharmaceutical-grade sodium hyaluronate powder designed for ophthalmic applications, supporting companies worldwide in the development of innovative eye care products.
High-Purity Ophthalmic-Grade Hyaluronic Acid for Lubricating Drops and Surgical Viscoelastic Applications
Sodium hyaluronate has become one of the most widely used biomaterials in ophthalmology. Its exceptional water-binding ability, biocompatibility, and viscoelastic properties make it ideal for both lubricating eye drops and surgical ophthalmic formulations. When supplied as a high-purity powder, sodium hyaluronate offers additional flexibility for formulation, sterilization, and storage.
In ophthalmic manufacturing, powder form allows producers to prepare solutions with precise viscosity and concentration according to the requirements of different clinical applications. From artificial tears designed to relieve dry eye symptoms to surgical viscoelastic solutions used during delicate procedures, sodium hyaluronate plays a critical role in maintaining tissue hydration and protecting sensitive ocular structures.
At Runxin Biotech, ophthalmic-grade sodium hyaluronate powder is produced through controlled fermentation and advanced purification processes. The result is a highly pure, stable material with low endotoxin levels and consistent molecular weight distribution. These characteristics ensure reliable performance during formulation and help meet strict regulatory requirements for ophthalmic products.
For companies developing eye drop formulations or surgical ophthalmic solutions, sodium hyaluronate powder offers a versatile starting point. It enables precise control over viscosity, solution clarity, and lubricating performance while maintaining excellent safety and compatibility with ocular tissues.
Sodium hyaluronate used for ophthalmic applications must meet higher purity and safety standards than cosmetic or topical grades. Several characteristics define its suitability for eye drops and surgical use.
Ophthalmic formulations require materials with extremely low impurity levels. High-grade sodium hyaluronate is purified to remove proteins, nucleic acids, and endotoxins that could cause irritation or inflammation.
Molecular weight directly affects viscosity, hydration capacity, and ocular retention time. Different ophthalmic formulations may require specific ranges to achieve the desired lubricating or viscoelastic effect.
Sodium hyaluronate can bind large amounts of water relative to its mass. This property allows eye drops to maintain moisture on the ocular surface and helps surgical formulations protect delicate tissues.
When properly dissolved, sodium hyaluronate forms a transparent, uniform solution that does not interfere with vision or surgical visualization.
Dry powder provides long shelf life and convenient transport while allowing manufacturers to prepare solutions at precise concentrations.
The eye is one of the most sensitive tissues in the human body. Materials used in ophthalmic formulations must combine biocompatibility with precise physical behavior.
Sodium hyaluronate meets these requirements through several mechanisms.
Hyaluronic acid naturally exists in the vitreous body and other connective tissues. Its presence in ophthalmic formulations supports compatibility and reduces the risk of adverse reactions.
In surgical procedures, sodium hyaluronate solutions provide cushioning and maintain space within the eye. This viscoelastic property protects delicate structures such as the corneal endothelium.
For dry eye treatment, sodium hyaluronate forms a hydrating film over the ocular surface. This film reduces friction between the eyelid and cornea and prolongs moisture retention.
Research suggests hyaluronic acid may contribute to epithelial repair and tissue regeneration, making it valuable in post-surgical recovery formulations.
Artificial tear products rely on sodium hyaluronate to mimic the natural lubrication of the tear film. The polymer’s ability to retain moisture and maintain viscosity makes it highly effective in dry eye treatments.
Many patients experience dry eye syndrome due to environmental conditions, prolonged screen exposure, aging, or medical conditions. Sodium hyaluronate eye drops help restore moisture and comfort.
A hydrated polymer layer protects epithelial cells and reduces irritation caused by blinking or environmental factors.
Compared with simple saline solutions, hyaluronic acid remains longer on the ocular surface, increasing therapeutic effectiveness.
Sodium hyaluronate can be combined with electrolytes, preservatives, or other ophthalmic ingredients depending on the product design.
Manufacturers often select specific molecular weights to optimize viscosity while ensuring comfortable application.
Sodium hyaluronate is also widely used in ophthalmic surgery as part of viscoelastic formulations.
During cataract procedures, viscoelastic solutions maintain space in the anterior chamber and protect corneal tissues.
The viscoelastic properties assist surgeons in manipulating tissues while reducing trauma.
Hyaluronic acid solutions can provide temporary support for delicate retinal structures.
Viscoelastic formulations help maintain stability during lens insertion.
These applications require extremely pure material with precise rheological properties.
Molecular weight strongly influences the performance of sodium hyaluronate solutions.
| Molecular Weight Range | Typical Function | Application Example |
|---|---|---|
| Low MW (0.3–0.8 MDa) | Lower viscosity | Light eye lubrication |
| Medium MW (0.8–1.5 MDa) | Balanced lubrication | Artificial tears |
| High MW (1.5–3.0 MDa) | Strong viscoelasticity | Surgical viscoelastic solutions |
Selecting the appropriate molecular weight allows formulators to tailor viscosity, lubrication, and retention time.
Many ophthalmic manufacturers prefer sodium hyaluronate in powder form rather than ready-made solutions.
| Feature | HA Powder | Pre-Made Solution |
|---|---|---|
| Shelf Life | Longer | Shorter |
| Transport Cost | Lower | Higher |
| Concentration Control | Flexible | Fixed |
| Storage Stability | Excellent | Limited |
Powder provides flexibility during formulation and simplifies logistics.
High-quality sodium hyaluronate begins with controlled microbial fermentation.
Modern fermentation technology produces hyaluronic acid with high purity and consistent molecular weight while avoiding animal-derived materials.
After fermentation, the material undergoes multiple purification steps to remove proteins, nucleic acids, and endotoxins.
Gentle drying processes preserve polymer structure while producing a stable powder suitable for long-term storage.
Manufacturing quality directly influences the safety and performance of ophthalmic products.
Ophthalmic sodium hyaluronate powder undergoes strict quality testing before release.
Typical parameters include:
| Parameter | Specification |
|---|---|
| Appearance | White or off-white powder |
| Molecular Weight | Customizable |
| Endotoxin | Very low |
| Protein Content | Minimal |
| Loss on Drying | Controlled |
| Solution Clarity | Clear |
These controls ensure consistent material performance in ophthalmic formulations.
Preparing sodium hyaluronate solutions from powder requires careful hydration.
General preparation steps include:
Add purified water or buffer solution to a sterile mixing vessel.
Slowly disperse sodium hyaluronate powder while stirring gently.
Allow sufficient hydration time to avoid clumping.
Adjust concentration according to formulation requirements.
Proper mixing conditions ensure uniform viscosity and clarity.
Packaging plays an important role in maintaining product quality.
Sodium hyaluronate powder is typically stored in moisture-proof containers with protective inner liners. Recommended storage conditions include:
Cool, dry environment
Protection from light
Controlled humidity
Under proper conditions, powder maintains stability for extended periods.
Different ophthalmic products require specific molecular weights and viscosities. Manufacturers often request customized material characteristics.
Runxin Biotech provides:
Multiple molecular weight options
Custom viscosity ranges
Technical documentation support
Sample supply for formulation testing
This flexibility allows manufacturers to develop both eye drop products and surgical viscoelastic solutions efficiently.
When developing ophthalmic formulations, consistency and purity are essential. Runxin Biotech focuses on controlled fermentation, advanced purification, and strict quality monitoring to ensure reliable sodium hyaluronate powder.
Key strengths include:
Long-term experience in hyaluronic acid production
Stable molecular weight control
Low endotoxin purification process
GMP-aligned manufacturing environment
Technical support for formulation development
These capabilities help pharmaceutical and medical device manufacturers create safe, high-performance ophthalmic products.
Medium molecular weight sodium hyaluronate is commonly used because it balances lubrication and comfort. However, the optimal range depends on the specific formulation.
Yes. Solutions prepared from sodium hyaluronate powder can be sterilized through appropriate filtration or terminal sterilization methods depending on formulation requirements.
When stored properly in sealed containers under dry conditions, the powder typically maintains stability for several years.
High-purity sodium hyaluronate produced through controlled fermentation is widely used in ophthalmic formulations and has a strong safety profile.
Sodium hyaluronate powder plays an essential role in both ophthalmic lubricating products and surgical viscoelastic formulations. Its ability to retain water, protect tissues, and provide controlled viscosity makes it a valuable ingredient for modern eye care solutions.
By selecting high-purity sodium hyaluronate produced through advanced fermentation and purification processes, manufacturers can develop eye drops and surgical formulations that meet strict safety and performance standards.
Runxin Biotech supplies pharmaceutical-grade sodium hyaluronate powder designed for ophthalmic applications, supporting companies worldwide in the development of innovative eye care products.
